Corrigendum to Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis [J Hepatol 75 (2021) 865-878]
It feels similar to any other shot quick, perhaps a little uncomfortable, but ultimately tolerable and over with before you can worry about it
As observed in the STEP trials, treatment discontinuations due to AEs occurred in 2.4%7.0% of participants receiving semaglutide, compared with 1.0%4.6% of those receiving placebo [13, 38,39,40,41,42,43,44,45,46]
Semaglutide is used to treat type 2 diabetes, reducing blood glucose levels by stimulating insulin production
International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: A joinpoint regression analysis